Sweden · Delayed Price · Currency is SEK Level Bio AB Statistics
Total Valuation
Level Bio AB has a market cap or net worth of SEK 22.57 million. The enterprise value is 21.01 million.
| Market Cap | 22.57M |
| Enterprise Value | 21.01M |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Level Bio AB has 68.40 million shares outstanding. The number of shares has increased by 3.94% in one year.
| Current Share Class | 68.40M |
| Shares Outstanding | 68.40M |
| Shares Change (YoY) | +3.94% |
| Shares Change (QoQ) | +14.20% |
| Owned by Insiders (%) | 17.90% |
| Owned by Institutions (%) | 13.88% |
| Float | 30.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| PB Ratio | 11.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.63 |
| EV / Sales | 0.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.01
| Current Ratio | 1.01 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -39.48 |
Financial Efficiency
Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -88.87%.
| Return on Equity (ROE) | -135.64% |
| Return on Assets (ROA) | -21.71% |
| Return on Invested Capital (ROIC) | -88.87% |
| Return on Capital Employed (ROCE) | -177.21% |
| Revenue Per Employee | 2.31M |
| Profits Per Employee | -349,022 |
| Employee Count | 11 |
| Asset Turnover | 2.19 |
| Inventory Turnover | 3.82 |
Taxes
| Income Tax | -322,095 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.81% in the last 52 weeks. The beta is 0.59, so Level Bio AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -5.81% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.33 |
| Relative Strength Index (RSI) | 49.66 |
| Average Volume (20 Days) | 27,263 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Level Bio AB had revenue of SEK 30.06 million and -4.54 million in losses. Loss per share was -0.07.
| Revenue | 30.06M |
| Gross Profit | 15.84M |
| Operating Income | -4.76M |
| Pretax Income | -4.86M |
| Net Income | -4.54M |
| EBITDA | -4.12M |
| EBIT | -4.76M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 1.56 million in cash and n/a in debt, giving a net cash position of 1.56 million or 0.02 per share.
| Cash & Cash Equivalents | 1.56M |
| Total Debt | n/a |
| Net Cash | 1.56M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.89M |
| Book Value Per Share | 0.03 |
| Working Capital | 93,000 |
Cash Flow
| Operating Cash Flow | -2.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.71%, with operating and profit margins of -15.82% and -15.09%.
| Gross Margin | 52.71% |
| Operating Margin | -15.82% |
| Pretax Margin | -16.17% |
| Profit Margin | -15.09% |
| EBITDA Margin | -13.72% |
| EBIT Margin | -15.82% |
| FCF Margin | n/a |
Dividends & Yields
Level Bio AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.94% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |